The WACC of TME Pharma NV (ALTME.PA) is 5.9%.
Range | Selected | |
Cost of equity | 5.10% - 6.70% | 5.90% |
Tax rate | 25.90% - 27.10% | 26.50% |
Cost of debt | 5.00% - 5.00% | 5.00% |
WACC | 5.1% - 6.7% | 5.9% |
Category | Low | High |
Long-term bond rate | 3.0% | 3.5% |
Equity market risk premium | 5.8% | 6.8% |
Adjusted beta | 0.37 | 0.4 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 5.10% | 6.70% |
Tax rate | 25.90% | 27.10% |
Debt/Equity ratio | 0.02 | 0.02 |
Cost of debt | 5.00% | 5.00% |
After-tax WACC | 5.1% | 6.7% |
Selected WACC | 5.9% | |